Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...
Personalized therapies for diabetes, while showing promise in international studies, is met with healthy skepticism from ...
According to a team of researchers at Baylor College of Medicine, Tongji University and collaborating institutions, weaning ...
Researchers in Japan pioneered reprogrammed cells 20 years ago. Now the country has given the first-ever authorizations to manufacture and sell medical products based on the technology.
According to a team of researchers at Baylor College of Medicine, Tongji University and collaborating institutions, weaning ...
According to a team of researchers at Baylor College of Medicine, Tongji University and collaborating institutions, weaning or switching from milk to ...
An innovative stem cell therapy approved for severe heart failure has been cleared for use in Japan. Here is why it matters ...
The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...
According to a team of researchers at Baylor College of Medicine, Tongji University and collaborating institutions, weaning or switching from milk to ...
India, March 18 -- Stem cell therapies using induced pluripotent stem cells have received conditional approval in Japan for treating Parkinson's disease and severe heart failure, advancing ...
Morning Overview on MSN
Japan approves first treatment made from reprogrammed human cells
Japan’s health ministry has endorsed two stem-cell therapies derived from induced pluripotent stem (iPS) cells, making them the first treatments of their kind to clear a national regulatory body ...
Aspen Neuroscience’s autologous, personalised stem cell therapy is set for a pivotal trial after it showed improved "ON" and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results